EUVIMEDEUVIMED entdecken
Crossref

Vitamin D promotes anticancer effects of low‐concentration cisplatin‐treated non‐small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF‐β/SMAD4 pathways

Heba Effat, Rehab S Abohashem, Marwa Sharaky, Mohammed Aly Mohammed

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.202400933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Heba Effat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Cisplatin, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most fatal kinds of cancer, with low survival rate because of delayed discovery and traditional therapy failure. This study intends to determine whether cisplatin plus vitamin D could be a more successful combination than standard monotherapy for non‐small‐cell lung cancer (NSCLC) by targeting the transforming growth factor beta (TGF‐β)/mothers against decapentaplegic homolog 4 (SMAD4) and janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathways and their downstream targets. Cytotoxic effects of vitamin D on MCF‐7, MCFR‐10, H1299, A549, and PC3 cell lines were evaluated by sulforhodamine‐B (SRB) assay, indicating that H1299 and A549 were the most effected cell lines; hence, they were selected for more investigation. IC 50 values of cisplatin against H1299 and A549 cells were established. Quantitative polymerase chain reaction (qPCR) was used to assess the expression levels of JAK2, STAT3, TGF‐β, Smad4, matrix metalloproteinase‐2 (MMP‐2), and MMP‐9 in both cell lines treated with vitamin D, cisplatin, or both. Results demonstrated remarkable expression of the aforementioned genes in H1299 and A549 cells, which was sharply decreased once the combination treatment was administered. Additionally, the protein expression of VEGF, MMP9, and angiotensin I, II is considerably inhibited by this combination. According to the obtained data, vitamin D and cisplatin combination therapy can target genes and proteins involved in cell adhesion, migration, and invasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsVitamin DHumansJanus Kinase 2STAT3 Transcription FactorSignal TransductionTransforming Growth Factor betaSmad4 ProteinDose-Response Relationship, DrugCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorStructure-Activity Relationship

Stichwörter der Autor:innen

NSCLCcisplatininvasion and metastasisvitamin D

Substanzen

CisplatinJanus Kinase 2STAT3 Transcription FactorAntineoplastic AgentsSTAT3 protein, humanVitamin DTransforming Growth Factor betaJAK2 protein, humanSmad4 ProteinSMAD4 protein, human

Autor:innen und Institutionen

  • Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
  • Stem Cell Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Giza, Egypt.
  • Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Förderung

  • None

Zitieren

APA

Effat, H., Abohashem, R. S., Sharaky, M., & Mohammed, M. A. (2025). Vitamin D promotes anticancer effects of low‐concentration cisplatin‐treated non‐small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF‐β/SMAD4 pathways. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400933

Vancouver

Effat H, Abohashem RS, Sharaky M, Mohammed MA. Vitamin D promotes anticancer effects of low‐concentration cisplatin‐treated non‐small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF‐β/SMAD4 pathways. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400933

BibTeX
@article{Effat2025,
  author = {Effat, Heba and Abohashem, Rehab S and Sharaky, Marwa and Mohammed, Mohammed Aly},
  title = {Vitamin D promotes anticancer effects of low‐concentration cisplatin‐treated non‐small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF‐β/SMAD4 pathways},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.202400933}
}
Kostenlos starten →